ArticleClinics (Sao Paulo, Brazil)

Neutralizing activity against Omicron subvariants BA.1, BA.2, and BA.4/5 following the third SARS-CoV-2 vaccination in cancer patients undergoing chemotherapy.

Jina Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.